Zomedica Pharmaceuticals Inc. is a veterinary pharmaceutical company that specializes in the development and commercialization of innovative medications and diagnostic products for companion animals. The company was founded in 2015 and is headquartered in Ann Arbor, Michigan, USA.
Zomedica's primary focus is on creating solutions for unmet medical needs in the veterinary industry. They aim to improve the quality of care for pets by developing and offering a range of therapeutic options for various conditions, including gastrointestinal, dermatological, ophthalmic, and metabolic diseases.
The company's flagship product is TRUFORMA®, a point-of-care diagnostic platform that allows veterinarians to run various tests for common health issues in dogs and cats. TRUFORMA® provides rapid and accurate results, enabling timely diagnosis and treatment for pets, and enhancing the overall veterinary care experience.
One of Zomedica's key strategies is to partner with veterinary clinics and hospitals to distribute its products and reach a broader market. By collaborating with established veterinary practices, Zomedica can effectively introduce its innovative solutions to a large customer base.
In addition to TRUFORMA®, Zomedica continues to develop and expand its product pipeline to address various medical needs in companion animals. The company is committed to advancing veterinary medicine through cutting-edge research and technology, contributing to improved pet health and wellness.